Chugai Pharmaceutical Co. Ltd.

Alecensa (alectinib): An ALK inhibitor used to treat ALK-positive non-small cell lung cancer, preventing cancer cell growth., Avastin (bevacizumab): A humanized monoclonal antibody targeting VEGF, inhibiting tumor blood vessel formation in various cancers., Herceptin (trastuzumab): A humanized monoclonal antibody targeting HER2 receptors, used in HER2-positive breast and gastric cancers., Kadcyla (trastuzumab emtansine): An antibody-drug conjugate combining trastuzumab and a chemotherapy agent, delivering targeted therapy to HER2-positive cancer cells., Perjeta (pertuzumab): A humanized monoclonal antibody that, in combination with trastuzumab, provides a dual blockade of HER2 signaling in breast cancer treatment., Polivy (polatuzumab vedotin): An anti-CD79b antibody-drug conjugate used for treating relapsed or refractory diffuse large B-cell lymphoma., Tecentriq (atezolizumab): A humanized monoclonal antibody inhibiting PD-L1, enhancing the immune system's ability to combat various cancers., Phesgo (pertuzumab, trastuzumab, and vorhyaluronidase alfa): A subcutaneous injection combining two monoclonal antibodies and an enzyme to treat HER2-positive breast cancer.

Actemra (tocilizumab): A humanized monoclonal antibody targeting the IL-6 receptor, used in rheumatoid arthritis and other inflammatory conditions., CellCept (mycophenolate mofetil): An immunosuppressant preventing organ rejection post-transplant by inhibiting lymphocyte proliferation., Edirol (eldecalcitol): An active vitamin D3 derivative used to treat osteoporosis by promoting calcium absorption and bone formation., Enspryng (satralizumab): A humanized monoclonal antibody targeting the IL-6 receptor, used for neuromyelitis optica spectrum disorder., Evrysdi (risdiplam): A treatment for spinal muscular atrophy that increases SMN protein production, improving motor function., Hemlibra (emicizumab): A bispecific monoclonal antibody bridging factors IXa and X, used to prevent bleeding in hemophilia A patients., Mircera (epoetin beta pegol): A long-acting erythropoiesis-stimulating agent treating anemia in chronic kidney disease by stimulating red blood cell production., PiaSky (crovalimab): A humanized monoclonal antibody targeting complement component C5, used in paroxysmal nocturnal hemoglobinuria., Ronapreve (casirivimab/imdevimab): A combination of two monoclonal antibodies used for COVID-19 treatment by neutralizing the SARS-CoV-2 virus., Tamiflu (oseltamivir): An antiviral medication inhibiting influenza virus replication, reducing flu symptoms and duration., Vabysmo (faricimab): A bispecific antibody targeting VEGF and Ang-2, used in retinal diseases like diabetic macular edema.